1. Home
  2. TOI vs CTKB Comparison

TOI vs CTKB Comparison

Compare TOI & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$3.12

Market Cap

444.1M

Sector

Health Care

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$5.64

Market Cap

433.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOI
CTKB
Founded
2007
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
444.1M
433.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TOI
CTKB
Price
$3.12
$5.64
Analyst Decision
Strong Buy
Hold
Analyst Count
3
4
Target Price
$6.00
$5.88
AVG Volume (30 Days)
3.1M
1.9M
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$461,039,000.00
$196,828,000.00
Revenue This Year
$21.71
N/A
Revenue Next Year
$20.58
$7.25
P/E Ratio
N/A
N/A
Revenue Growth
21.67
N/A
52 Week Low
$0.15
$2.37
52 Week High
$4.88
$7.30

Technical Indicators

Market Signals
Indicator
TOI
CTKB
Relative Strength Index (RSI) 39.14 66.53
Support Level $2.88 $5.15
Resistance Level $3.32 $5.95
Average True Range (ATR) 0.35 0.43
MACD -0.06 0.05
Stochastic Oscillator 19.12 66.15

Price Performance

Historical Comparison
TOI
CTKB

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: